Clinical Trials

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Recurrence

NCT06245603 2026-02-06

Hydeal Cyst

200 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05223491 2026-01-16

En Bloc Transurethral Resection of Non-muscle Invasive Bladder Cancer

Phase NA Completed

220 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT07347132 2026-01-16

Comparison of Pathological Outcome and Recurrence Rate Between En Bloc and Conventional Transurethral Resection of Bladder Tumor

Phase NA Completed

116 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Recurrence

NCT07339761 2026-01-14

SPICE

30 enrolled

Phase NA Active not recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT07252297 2025-11-26

NMIBC

177 enrolled

Non-Muscle Invasive Bladder Neoplasms, Disease

NCT07231809 2025-11-21

HIVEC

50 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma

NCT07187063 2025-09-22

Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer

56 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT07036731 2025-06-25

A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing

428 enrolled

Non-Muscle Invasive Bladder Neoplasms, Fanconi Syndrome

NCT06678633 2025-05-29

T-Control® Safety for Cytostatics Management

16 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06990061 2025-05-25

BRACE

50 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06982690 2025-05-21

Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial

370 enrolled